Lifeward Ltd. current report, Q1 FY2015

Full document

Business Context and Reporting Period

This Form 6-K filing by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) covers the month of February 2015, with the report dated February 27, 2015. The filing addresses corporate governance updates regarding the composition of the Board of Directors' committees.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is non-financial in nature and focuses solely on administrative and governance matters.

Material Changes

The primary material change reported is the restructuring of the Board of Directors' committees effective February 26, 2015:

  • Audit Committee: Mr. Wayne B. Weisman was appointed as a member. He resigned from the compensation committee to assume this role. The committee now consists of Messrs. Weisman and Muir, and Dr. Poduska.
  • Compensation Committee: Mr. Aryeh (Arik) Dan was appointed as a member. The committee now consists of Messrs. Dan and Muir, and Dr. Poduska.

Guidance, Outlook, and Risks

Management Commentary and Governance Compliance:

  • Audit Committee Independence: While Mr. Weisman is independent under Nasdaq rules, he is not considered independent under Rule 10A-3(b)(1) of the Exchange Act due to his affiliation with SCP Vitalife Partners, a greater than 10% shareholder. The other two members are fully independent.
  • Phase-in Period: The Company is permitted to phase in full director independence pursuant to Nasdaq rules for companies in their first year following listing. Management expects to have a fully independent audit committee within one year of listing.
  • Compensation Committee Independence: All three members of the compensation committee (Messrs. Dan and Muir, and Dr. Poduska) are independent under Nasdaq rules.

The filing contains no financial guidance, market outlook, or discussion of financial risks or contingencies.

Investor Verification Checklist

  • Verify the current independence status of Mr. Wayne B. Weisman regarding Rule 10A-3(b)(1) and his relationship with SCP Vitalife Partners.
  • Confirm the timeline for achieving a fully independent audit committee as per the one-year phase-in expectation.
  • Review the Company's Form 20-F for the most recent financial data, as this 6-K contains no financial metrics.